NISA GREGSON: Open Payments
NPI 1700308079 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 65 payments from 13 companies in 2025. Trend: 2023 $1,056 · 2024 $1,242 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 16 | $213 |
| ABBVIE INC. | 10 | $186 |
| PFIZER INC. | 19 | $150 |
| Axsome Therapeutics, Inc. | 2 | $143 |
| PROTEGA PHARMACEUTIALS INC | 3 | $83 |
| Collegium Pharmaceutical, Inc. | 4 | $76 |
| Averitas Pharma Inc. | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
| Lundbeck LLC | 2 | $48 |
| Fidia Pharma USA Inc. | 2 | $43 |
Products named: PROLATE, QULIPTA, Symbravo, NURTEC ODT, ROXYBOND, Belbuca, QUTENZA, RELISTOR.
Industry payments across KS — which companies pay providers there.
